Borin, Marie T <br/><br/>
Revefenacin, a Long-Acting Muscarinic Antagonist, Does Not Prolong QT Interval in Healthy Subjects: Results of a Placebo- and Positive-Controlled Thorough QT Study.  [electronic resource] 

 -  Clinical pharmacology in drug development  01 2020 
 - 130-139 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2160-7648 
<br/><br/><label>Standard No.: </label>10.1002/cpdd.732  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Benzamides--blood<br/>Carbamates--blood<br/>Cross-Over Studies<br/>Double-Blind Method<br/>Electrocardiography--drug effects<br/>Female<br/>Healthy Volunteers<br/>Heart Rate--drug effects<br/>Humans<br/>Long QT Syndrome<br/>Male<br/>Middle Aged<br/>Muscarinic Antagonists--blood<br/>Young Adult